SPECIAL NOTICE
A -- NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
- Notice Date
- 3/3/2016
- Notice Type
- Special Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- S16-107
- Archive Date
- 3/26/2016
- Point of Contact
- SBO Help Desk,
- E-Mail Address
-
NCIOASupport@centeva.com
(NCIOASupport@centeva.com)
- Small Business Set-Aside
- N/A
- Description
- National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of solicitation for offers. In accordance with FAR 15.201(d), this special notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to: 1) publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR); and 2) increase participation by qualified HUBZone small business, small, small disadvantaged, women-owned small business, veteran-owned small business and service-disabled veteran-owned small business concerns, as applicable. The FNLCR is a Government-Owned Contractor-Operated (GOCO) Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. for the National Cancer Institute (NCI) under Prime Contract No. HHSN261200800001E, which provides Operations and Technical Support (OTS) for the Frederick National Lab. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this notice as no information is being requested. Please be advised that any submissions provided despite the aforementioned notice that no information is requested become Government property and will not be returned, nor will there be any ensuing discussions or debriefings of any responses. Responses submitted to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any. Background and Contact Information Background: The NCI-MATCH (Molecular Analysis for Therapy Choice) is a clinical trial that analyzes patients' tumor to determine whether they contain genetic abnormalities which are matched to a targeted drug or treatment combination being used in the study. More information about the trial can be found at http://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/nci-match. It is estimated that up to 3,000 patients will need to have tumors profiled in order to enroll approximately 500-1000 patients. A network of four CLIA laboratories with proficiencies in next generation sequencing using the PGM platform has been established to support the sequencing arm of NCI-MATCH clinical trial. The network is seeking to expand in order to support the demand and interest in NCI clinical trial. In particular, a pediatric trial, similar to the NCI-MATCH trial, is in development and it is intended that the clinical laboratory network will be capable of supporting NCI clinical trials (adult and/or pediatric). The same sequencing assay will be used to support both studies. Contact: Lori Keisling @ lori.keisling@fnlcr.nih.gov For information concerning other opportunities with the FNLCR, please refer to: http://ncioa.cancer.gov/oa-internet/sbo/welcome.jsp
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/S16-107/listing.html)
- Record
- SN04039318-W 20160305/160304000259-4fc71bd149948c72e2f3c1e984cb9365 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |